DOJ Targets Boston Scientific With Stent Subpoena

Law360, New York (August 11, 2008, 12:00 AM EDT) -- Boston Scientific has announced it received a subpoena from the U.S. Department of Justice in connection with the agency's investigation of the marketing of bile-duct stents, less than a week after Johnson & Johnson subsidiary Cordis Corp. and Abbott Laboratories made similar announcements.

In its 10-Q form filed with the U.S. Securities and Exchange Commission on Friday, Boston Scientific said it received a subpoena in June from the U.S. attorney's office in Massachusetts.

The filing also said New Hampshire's attorney general subpoenaed Boston Scientific on July...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.